Adial Pharmaceuticals ADIL
NASDAQ ADIL
$4.16 +0.34 (+8.90%)
As of: Oct 21, 2026 · 12:04 PM EDT

Adial Pharmaceuticals (ADIL) Receivables (2024 - 2025)

Updated

Adial Pharmaceuticals' Receivables came in at $41,758 for Q4 2025, down 25.5% from $56,020 a year earlier.

Analysis

Adial Pharmaceuticals (ADIL) Receivables (2024 - 2025) Analysis & Trends

  • Going back by year, Receivables was $56,020 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Eli Lilly 1,133.15 Bn 1,101.73 Bn 19.71 Bn 23.48 Bn
2 Johnson & Johnson 616.41 Bn 534.94 Bn 17.26 Bn 19.05 Bn
3 AbbVie 501.01 Bn 474.12 Bn 12.70 Bn 13.82 Bn
4 Merck 367.15 Bn 321.53 Bn 12.21 Bn 12.56 Bn
5 Novartis Ag 298.00 Bn 261.99 Bn 11.24 Bn 9.64 Bn
6 Astrazeneca 261.56 Bn 235.25 Bn 12.86 Bn 15.68 Bn
7 Amgen 235.40 Bn 190.80 Bn 7.24 Bn 10.23 Bn
8 Gilead Sciences 190.38 Bn 164.57 Bn 6.22 Bn 5.06 Bn
9 Pfizer 169.76 Bn 116.40 Bn 10.94 Bn 12.49 Bn
10 Adial Pharmaceuticals 19.23 Mn -24.56 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 41,758.00
Dec 31, 2024 56,020.00
API Access

Adial Pharmaceuticals Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=ADIL&period=max&api_key=YOUR_API_KEY